JOHNSON & JOHNSON: 13F holdings
CIK 2004062026Q2
| Positions | 15 |
|---|
| Reported value | $798.7m |
|---|
| Filed | 2026-08-06 |
|---|
Change since last quarter
| Positions | 15 (-1 vs prior quarter) |
|---|
| Reported value | $798.7m (+22.4%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| PTGX PROTAGONIST THERAPEUTICS INC | 2,449,183 | $300.2m | 37.6% |
| NANOBIOTIX | 5,623,816 | $212.0m | 26.5% |
| MEIRAGTX HLDGS PLC | 6,641,064 | $89.7m | 11.2% |
| RAPP RAPPORT THERAPEUTICS INC | 1,784,517 | $74.4m | 9.3% |
| CTNM CONTINEUM THERAPEUTICS INC | 1,979,173 | $32.4m | 4.1% |
| LEGN LEGEND BIOTECH CORP | 814,586 | $23.5m | 2.9% |
| CVRX CVRX INC | 4,024,861 | $20.7m | 2.6% |
| XNCR XENCOR INC | 748,062 | $12.0m | 1.5% |
| CBRS CEREBRAS SYSTEMS INC | 53,586 | $11.8m | 1.5% |
| FATE FATE THERAPEUTICS INC | 3,379,064 | $9.1m | 1.1% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="200406")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples